BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20843082)

  • 1. Potent, highly selective, and orally bioavailable gem-difluorinated monocationic inhibitors of neuronal nitric oxide synthase.
    Xue F; Li H; Delker SL; Fang J; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Am Chem Soc; 2010 Oct; 132(40):14229-38. PubMed ID: 20843082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simplified 2-aminoquinoline-based scaffold for potent and selective neuronal nitric oxide synthase inhibition.
    Cinelli MA; Li H; Chreifi G; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2014 Feb; 57(4):1513-30. PubMed ID: 24472039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenyl Ether- and Aniline-Containing 2-Aminoquinolines as Potent and Selective Inhibitors of Neuronal Nitric Oxide Synthase.
    Cinelli MA; Li H; Pensa AV; Kang S; Roman LJ; Martásek P; Poulos TL; Silverman RB
    J Med Chem; 2015 Nov; 58(21):8694-712. PubMed ID: 26469213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate.
    Cinelli MA; Reidl CT; Li H; Chreifi G; Poulos TL; Silverman RB
    J Med Chem; 2020 May; 63(9):4528-4554. PubMed ID: 32302123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Aminopyridines with a Truncated Side Chain To Improve Human Neuronal Nitric Oxide Synthase Inhibitory Potency and Selectivity.
    Kang S; Li H; Tang W; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2015 Jul; 58(14):5548-60. PubMed ID: 26120733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-guided design of selective inhibitors of neuronal nitric oxide synthase.
    Huang H; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Med Chem; 2013 Apr; 56(7):3024-32. PubMed ID: 23451760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for dipeptide amide isoform-selective inhibition of neuronal nitric oxide synthase.
    Flinspach ML; Li H; Jamal J; Yang W; Huang H; Hah JM; Gómez-Vidal JA; Litzinger EA; Silverman RB; Poulos TL
    Nat Struct Mol Biol; 2004 Jan; 11(1):54-9. PubMed ID: 14718923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aromatic reduced amide bond peptidomimetics as selective inhibitors of neuronal nitric oxide synthase.
    Hah JM; Martásek P; Roman LJ; Silverman RB
    J Med Chem; 2003 Apr; 46(9):1661-9. PubMed ID: 12699384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design, synthesis, and biological evaluation of lipophilic-tailed monocationic inhibitors of neuronal nitric oxide synthase.
    Xue F; Huang J; Ji H; Fang J; Li H; Martásek P; Roman LJ; Poulos TL; Silverman RB
    Bioorg Med Chem; 2010 Sep; 18(17):6526-37. PubMed ID: 20673724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclopropyl- and methyl-containing inhibitors of neuronal nitric oxide synthase.
    Li H; Xue F; Kraus JM; Ji H; Labby KJ; Mataka J; Delker SL; Martásek P; Roman LJ; Poulos TL; Silverman RB
    Bioorg Med Chem; 2013 Mar; 21(5):1333-43. PubMed ID: 23352768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of selective neuronal nitric oxide synthase inhibitors for the prevention and treatment of neurodegenerative diseases.
    Silverman RB
    Acc Chem Res; 2009 Mar; 42(3):439-51. PubMed ID: 19154146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective monocationic inhibitors of neuronal nitric oxide synthase. Binding mode insights from molecular dynamics simulations.
    Huang H; Ji H; Li H; Jing Q; Labby KJ; Martásek P; Roman LJ; Poulos TL; Silverman RB
    J Am Chem Soc; 2012 Jul; 134(28):11559-72. PubMed ID: 22731813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In search of potent and selective inhibitors of neuronal nitric oxide synthase with more simple structures.
    Jing Q; Li H; Fang J; Roman LJ; Martásek P; Poulos TL; Silverman RB
    Bioorg Med Chem; 2013 Sep; 21(17):5323-31. PubMed ID: 23867386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chiral linkers to improve selectivity of double-headed neuronal nitric oxide synthase inhibitors.
    Jing Q; Li H; Chreifi G; Roman LJ; Martásek P; Poulos TL; Silverman RB
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5674-9. PubMed ID: 23993333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for isoform-selective inhibition in nitric oxide synthase.
    Poulos TL; Li H
    Acc Chem Res; 2013 Feb; 46(2):390-8. PubMed ID: 23030042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances toward improving the bioavailability of neuronal nitric oxide synthase inhibitors.
    Huang H; Silverman RB
    Curr Top Med Chem; 2013; 13(7):803-12. PubMed ID: 23578024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent, Selective, and Membrane Permeable 2-Amino-4-Substituted Pyridine-Based Neuronal Nitric Oxide Synthase Inhibitors.
    Vasu D; Do HT; Li H; Hardy CD; Awasthi A; Poulos TL; Silverman RB
    J Med Chem; 2023 Jul; 66(14):9934-9953. PubMed ID: 37433128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural Basis for Isoform Selective Nitric Oxide Synthase Inhibition by Thiophene-2-carboximidamides.
    Li H; Evenson RJ; Chreifi G; Silverman RB; Poulos TL
    Biochemistry; 2018 Nov; 57(44):6319-6325. PubMed ID: 30335983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of zinc in isoform-selective inhibitor binding to neuronal nitric oxide synthase .
    Delker SL; Xue F; Li H; Jamal J; Silverman RB; Poulos TL
    Biochemistry; 2010 Dec; 49(51):10803-10. PubMed ID: 21138269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structures of constitutive nitric oxide synthases in complex with de novo designed inhibitors.
    Igarashi J; Li H; Jamal J; Ji H; Fang J; Lawton GR; Silverman RB; Poulos TL
    J Med Chem; 2009 Apr; 52(7):2060-6. PubMed ID: 19296678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.